To Control of Refractory Chronic Cough: Approach to Pathological Diversity Using Biomarkers
Not Applicable
Recruiting
- Conditions
- chronic cough
- Registration Number
- JPRN-UMIN000047523
- Lead Sponsor
- agoya City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Current smokers and past smokers with 20 pack-years or more (2) Patients with frequent visits who have difficulty following the course (3) Patients with other obvious respiratory diseases such as lung cancer and interstitial lung disease (4) Pregnant and lactating patients (5) Other patients who are judged to be inappropriate as subjects by the principal investigators or the co-investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients whose cough VAS has improved by 30 or more or 50% or more from the pretreatment value at 12 weeks after the start of treatment are defined as the responders, and the other patients are defined as non-responders. Comparing clinical characteristics and biomarkers at the baseline between the responders and the non-responders.
- Secondary Outcome Measures
Name Time Method